Join us for a discussion on the key factors to be considered in informing an ethical response to the challenges that lay ahead in ensuring fair and equitable access.
Speakers:
- Achal Prabhala, Fellow at the Shuttleworth Foundation and Coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil, and South Africa.
- Ellen ‘t Hoen, Director of Medicines Law & Policy, founder of the Medicines Patent Pool, and a lawyer and public health advocate with over 30 years of experience working on pharmaceutical and intellectual property policies.
- Dr Stefan Swartling Peterson, Chief of Health and Associate Director, Programme Division, at UNICEF.
- Dr Sheuli Porkess, Executive Director, Research, Medical and Innovation at the Association of the British Pharmaceutical Industry, and experienced Medical Affairs Physician.
A global research effort is underway to develop effective treatments and vaccines for COVID-19. With hundreds of research projects and trials in development worldwide, the race is on to find a safe and effective vaccine to end the pandemic and enable a revival of social and economic activity.
The COVID-19 pandemic has already disproportionately affected disadvantaged populations, both within and between countries. Without ethical leadership and changes to current systems, the effects will widen inequality, hitting disadvantaged populations and low-income countries hardest.
